Literature DB >> 9105755

Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

M T LaRocco1, S J Burgert.   

Abstract

Over the past quarter century, tremendous technological advances have been made in bone marrow and solid organ transplantation. Despite these advances, an enduring problem for the transplant recipient is infection. As immunosuppressive regimens have become more systematic, it is apparent that different pathogens affect the transplant recipient at different time points in the posttransplantation course, since they are influenced by multiple intrinsic and extrinsic factors. An understanding of this evolving risk for infection is essential to the management of the patient following transplantation and is a key to the early diagnosis and treatment of infection. Likewise, diagnosis of infection is dependent upon the quality of laboratory support, and services provided by the clinical microbiology laboratory play an important role in all phases of clinical transplantation. These include the prescreening of donors and recipients for evidence of active or latent infection, the timely and accurate microbiologic evaluation of the transplant patient with suspected infection, and the surveillance of asymptomatic allograft recipients for infection. Expert services in bacteriology, mycology, parasitology, virology, and serology are needed and communication between the laboratory and the transplantation team is paramount for providing clinically relevant, cost-effective diagnostic testing.

Entities:  

Mesh:

Year:  1997        PMID: 9105755      PMCID: PMC172920          DOI: 10.1128/CMR.10.2.277

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  296 in total

Review 1.  Direct detection of cytomegalovirus in peripheral blood leukocytes--a review of the antigenemia assay and polymerase chain reaction.

Authors:  T H The; M van der Ploeg; A P van den Berg; A M Vlieger; M van der Giessen; W J van Son
Journal:  Transplantation       Date:  1992-08       Impact factor: 4.939

2.  Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report.

Authors:  R Villalba; G Fornés; M A Alvarez; J Román; V Rubio; M Fernández; J M García; M Viñals; A Torres
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

3.  Primary hepatocellular carcinoma after orthotopic liver transplantation for chronic hepatitis B infection.

Authors:  V A Luketic; M L Shiffman; J B McCall; M P Posner; A S Mills; R L Carithers
Journal:  Ann Intern Med       Date:  1991-02-01       Impact factor: 25.391

4.  Fatal adenovirus meningoencephalitis in a bone marrow transplant patient.

Authors:  D Davis; P J Henslee; W R Markesbery
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

Review 5.  Disseminated fusarial infection in the immunocompromised host.

Authors:  S E Richardson; R M Bannatyne; R C Summerbell; J Milliken; R Gold; S S Weitzman
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

6.  Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient.

Authors:  W R Drobyski; K K Knox; D Majewski; D R Carrigan
Journal:  N Engl J Med       Date:  1994-05-12       Impact factor: 91.245

7.  Infections after liver transplantation. An analysis of 101 consecutive cases.

Authors:  S Kusne; J S Dummer; N Singh; S Iwatsuki; L Makowka; C Esquivel; A G Tzakis; T E Starzl; M Ho
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

8.  Pneumococcal infections after human bone-marrow transplantation.

Authors:  D J Winston; G Schiffman; D C Wang; S A Feig; C H Lin; E L Marso; W G Ho; L S Young; R P Gale
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391

9.  Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

Authors:  M Ho; G Miller; R W Atchison; M K Breinig; J S Dummer; W Andiman; T E Starzl; R Eastman; B P Griffith; R L Hardesty
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

10.  Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.

Authors:  P L Hibberd; N E Tolkoff-Rubin; A B Cosimi; R T Schooley; D Isaacson; M Doran; A Delvecchio; F L Delmonico; H Auchincloss; R H Rubin
Journal:  Transplantation       Date:  1992-01       Impact factor: 4.939

View more
  5 in total

1.  Strong antifungal activity of SS750, a new triazole derivative, is based on its selective binding affinity to cytochrome P450 of fungi.

Authors:  Masaru Matsumoto; Kazuya Ishida; Akihiro Konagai; Kazunori Maebashi; Takemitsu Asaoka
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.

Authors:  Marcel R M van den Brink; Robert R Jenq; Yusuke Shono; Melissa D Docampo; Jonathan U Peled; Suelen M Perobelli; Enrico Velardi; Jennifer J Tsai; Ann E Slingerland; Odette M Smith; Lauren F Young; Jyotsna Gupta; Sophia R Lieberman; Hillary V Jay; Katya F Ahr; Kori A Porosnicu Rodriguez; Ke Xu; Marco Calarfiore; Hendrik Poeck; Silvia Caballero; Sean M Devlin; Franck Rapaport; Jarrod A Dudakov; Alan M Hanash; Boglarka Gyurkocza; George F Murphy; Camilla Gomes; Chen Liu; Eli L Moss; Shannon B Falconer; Ami S Bhatt; Ying Taur; Eric G Pamer
Journal:  Sci Transl Med       Date:  2016-05-18       Impact factor: 17.956

3.  In vitro synergistic activity of diketopiperazines alone and in combination with amphotericin B or clotrimazole against Candida albicans.

Authors:  S Nishanth Kumar; Bala Nambisan; C Mohandas; A Sundaresan
Journal:  Folia Microbiol (Praha)       Date:  2013-02-28       Impact factor: 2.099

4.  High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections.

Authors:  Lixin Zhang; Kezhi Yan; Yu Zhang; Ren Huang; Jiang Bian; Chuansen Zheng; Haixiang Sun; Zhihui Chen; Nuo Sun; Rong An; Fangui Min; Weibo Zhao; Ying Zhuo; Jianlan You; Yongjie Song; Zhenyan Yu; Zhiheng Liu; Keqian Yang; Hong Gao; Huanqin Dai; Xiaoli Zhang; Jian Wang; Chengzhang Fu; Gang Pei; Jintao Liu; Si Zhang; Michael Goodfellow; Yuanying Jiang; Jun Kuai; Guochun Zhou; Xiaoping Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

5.  Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus.

Authors:  M Boukhvalova; J C G Blanco; A R Falsey; J Mond
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.